X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (3) 3
acquired-resistance (2) 2
aged (2) 2
cell lung-cancer (2) 2
egfr (2) 2
erlotinib (2) 2
female (2) 2
gefitinib (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
middle aged (2) 2
mutation (2) 2
acne (1) 1
activating egfrm plus (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adult (1) 1
afatinib (1) 1
afatinib - therapeutic use (1) 1
afatinib bibw 2992 (1) 1
aged, 80 and over (1) 1
alleles (1) 1
amino acid substitution (1) 1
analysis (1) 1
antitumor-activity (1) 1
biopsy (1) 1
breast-cancer (1) 1
carcinoma, non-small-cell lung - diagnosis (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
care and treatment (1) 1
chemotherapy (1) 1
cytology (1) 1
diarrhea (1) 1
disease (1) 1
dna mutational analysis - methods (1) 1
drug administration schedule (1) 1
drug resistance (1) 1
drug-related side effects and adverse reactions - epidemiology (1) 1
eastern cooperative oncology group (1) 1
ecog (1) 1
egfr mutation-positive (1) 1
egfrm (1) 1
egfrm + nsclc (1) 1
egfrm plus nsclc (1) 1
epidermal growth factor receptor (1) 1
epidermal growth factor receptors (1) 1
erbb receptors - genetics (1) 1
exons (1) 1
ffpe (1) 1
formalin-fixed, paraffin-embedded (1) 1
genetic aspects (1) 1
her signaling pathways (1) 1
her signalling pathways (1) 1
incidence (1) 1
inhibitor (1) 1
irreversible egfr (1) 1
japan - epidemiology (1) 1
japanese patients (1) 1
lung cancer, non-small cell (1) 1
lung diseases (1) 1
lung neoplasms - diagnosis (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - genetics (1) 1
lung neoplasms - pathology (1) 1
marketing (1) 1
medical research (1) 1
medicine, experimental (1) 1
multicenter (1) 1
multicenter studies as topic (1) 1
mutation rate (1) 1
neoplasm grading (1) 1
neoplasm recurrence, local - drug therapy (1) 1
neoplasm recurrence, local - pathology (1) 1
neoplasm staging (1) 1
non-small cell lung cancer (1) 1
non-small cell lung carcinoma (1) 1
nsclc (1) 1
nsclc-patients (1) 1
original (1) 1
original article (1) 1
panher inhibitors (1) 1
patients (1) 1
performance status (1) 1
phase-ii trial (1) 1
post-marketing observational study (1) 1
prognosis (1) 1
progressive disease (1) 1
prospective studies (1) 1
protein kinase inhibitors - therapeutic use (1) 1
real-world data (1) 1
receptor, epidermal growth factor - genetics (1) 1
resistance t790m mutations (1) 1
respiratory system (1) 1
safety (1) 1
specimens (1) 1
standard deviation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 01/2015, Volume 5
Purpose: Hyper-activation of the HER (erbB) family receptors, HER 1-4, leads to upregulation of the three vital signaling pathways: mitogen activated protein... 
targeted therapy | panHER inhibitors | RESISTANCE T790M MUTATIONS | ACQUIRED-RESISTANCE | ANTITUMOR-ACTIVITY | IRREVERSIBLE EGFR | EGFR | HER signaling pathways | CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | BREAST-CANCER | PHASE-II TRIAL | ONCOLOGY | AFATINIB BIBW 2992 | drug resistance | ACTIVATING EGFRM PLUS | PanHER inhibitors | Drug Resistance | HER signalling pathways
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.